Dear AVF Members,

On November 15, 2021, the Board of Directors of the AVF and the Board of Directors of the AVFF voted unanimously to approve a merger of the AVF and AVFF. We have included links to the Plan of Merger and a copy of the article that will appear in the upcoming issue of the AVF newsletter, Vein Specialist, for your review. We will be hosting a Town Hall Meeting (webinar format) on Tuesday, November 23, at 6:00pm ET to address this topic for our members and answer any questions you may have. Please look for a calendar invite. Until then, we invite you to make any comments or ask any questions by emailing us at info@veinforum.org.

Immediately following the Town Hall Meeting, we will be distributing a ballot to voting members of the AVF and encourage all voting members to vote. Voting members of the AVF include the following membership categories: Physician Members (US and International), Distinguished Fellows, and Senior Member. Voting will close on December 15, 2021, as required by our bylaws.

We look forward to hearing from you.

Antonios Gasparis, MD
President, American Venous Forum

Harold Welch, MD
President, American Venous Forum Foundation

The post The Merger: AVF + AVFF = AVF appeared first on American Venous Forum.

We recently informed you of serious concerns about the impact that the proposed CMS PFS will have on your practices if it goes into effect without modification Jan 1, 2022.  This could result in a MORE THAN 20% reduction in CMS payments to some of you.  AVF leadership is working collaboratively with a group of professional societies to better understand the proposals and to have them changed!  These rules are lengthy and complex. As we work through this administrative crisis, we believe it is important for our members to understand that there are many aspects of this proposed rule. While you are welcome to review the 804 page document of the proposed rule (published in the Federal Register on July 23, 2021 – Docket number CMS-1751-P) or the CMS fact sheet, the AMA has provided a summary that, though still a bit technical, provides a good summary of the potential impacts to the provider community as a whole.

Be assured that the Health Policy Committee and AVF Leadership are advocating on your behalf.  

Mark Iafrati

Chair AVF Health Policy Committee

The post CMS Proposed Physician Fee Schedule (PFS): The Rest of the Story appeared first on American Venous Forum.

Dr. Monahan spoke with Staffers from California Senators Feinstein and Padilla, and Representatives McClintock, Barbara Lee, and Lieu. Dr. Iafrati met with Tennessee Representatives Good and Cooper, Tennessee Senators Blackburn and Haggerty and Virginia Senators Kaine and Warner.

These discussions were focused on four urgent issues with potential legislative fixes, all of which have currently drafted bills, and therefore provide opportunities for immediate ACTION.

1) Push back against poorly administered and burdensome Prior Authorization rules instituted by Medicare Advantage programs.
2) Address the looming shortage of Venous Specialists (and the overall physician Work Force) by increasing funded residency positions and increasing the pipeline of providers to fill the slots.
3) Roll back the proposed changes to Medicare Payments which unevenly and unfairly slash funding to venous providers (potentially >20% if your practice is primarily office based)
4) Provide for mental health services for medical providers.

Read below to learn more details on our proposed path forward then call, email, snail mail your Representatives and Senators to let them know how important these issues are to you.

1. Co-Sponsor and Support Passage of H.R. 3173, “Improving Seniors’ Timely Access to Care Act of 2021”
   • Current prior authorization requirements for pre-approval of vascular ultrasound and other medical procedures under Medicare Advantage (MA) plans often delay the provision of critical treatment supported by evidence-based clinical guidelines. Delays in treatment can have severe consequences for patients, including those who have suffered a stroke or patients with a blood clot in their leg that could result in leg amputation.
   • H.R. 3173 will standardize and streamline the prior authorization process under MA plans by automating the prior authorization process, increasing transparency, requiring real-time decisions by MA plans, ensuring prior authorization requests are reviewed by qualified medical personnel, and encouraging plans to adopt prior authorization programs that adhere to evidence-based medical guidelines in consultation with physicians under MA plans.
2. Co-Sponsor and Support Passage of H.R. 2256/S. 834, “The Resident Physician Shortage Act”
   • The current nationwide physician workforce shortage is an urgent public health problem that is only going to get worse. The latest data from the Association of American Medical Colleges projects a shortage of between 37,800 and 124,000 physicians by 2034. A shortage of non-primary care specialty physicians of between 21,000 and 77,100 is also projected by 2034, including between 15,800 and 30,200 for surgical specialties. Furthermore, the COVID-19 pandemic has put additional serious strains on this workforce as it continues to respond to this national emergency.
   • H.R. 2256/S. 834, will help address the nationwide shortage of physicians and the acute shortage of vascular surgeons by adding 14,000 new Medicare Graduate Medical Education (GME) slots over seven years. This legislation will build on the 1,000 additional Medicare-funded residency positions included in the Consolidated Appropriations Act of 2021.
   • H.R. 2256/S. 834 legislation defers loan repayment for surgical specialties, makes medical school more accessible and affordable, encourages appropriate Visa policies to ensure International Medical Graduates and medical students can study and practice medicine in the United States, and supports mental health services for physicians.
   • Vascular residencies and fellowships are turning out about 160 new surgeons a year, but health economists predict this will be woefully inadequate and will result in a reduction of surgeons trained to deliver vascular care in the U.S. as some 65 million baby boomers enter the age group that suffers most from vascular disease. Vulnerable populations, such as the nation’s elderly and patients in rural and underserved areas, will be most adversely impacted by the growing physician workforce shortage.
3. Oppose Medicare Payment Reductions for Surgical Care Estimated to Result in a >9% Payment Cut
   • Congress delayed the most drastic cuts for 2021, but last year’s action was only a temporary fix. Congress did this by adding a 3.75% Conversion Factor (CF) increase for all services — avoided significant disruptions to care for Medicare beneficiaries, supported small health care businesses — especially in rural and underserved areas and continuing the suspension of the -2% Medicare sequestration during the Public Health Emergency.
   • Compounding these payment cuts are Medicare’s budget-neutral financing system and updates to the CF that have failed to keep up with inflation. The CF is the dollar multiplier that Medicare applies to relative value units (RVUs) to calculate reimbursement for a particular service or procedure under Medicare’s fee-for-service system. The CF today is only about 50% of what it would have been if it had simply been indexed to general inflation starting in 1998, when the single CF was established.
   • Furthermore, vascular surgeons have seen a disproportionate decrease in inflation-adjusted reimbursement in comparison to other surgical specialties over the last decade. A recent study published in the Annals of Vascular Surgery reported that inflation-adjusted Medicare reimbursement rates for the 20 most common vascular surgical procedures decreased by more than 20% in the last decade, in comparison to an inflation-adjusted reimbursement rate decrease over the same period of 12% for general surgery and 8% for neurosurgery.
   • Recent changes in the Physician Fee schedule, proposed by CMS have appropriately increased the Clinical Labor Staff Rates. Payment for these non-physician staffers is financed by decreases in the reimbursement for supplies and equipment in outpatient settings. These Practice Expense (PE) changes will have a disproportionately severe impact on vascular surgeons/venous providers who utilize office-based procedures and Office-Based Labs (OBLs). If unmitigated the impact to office based vascular practices could reduce reimbursement to these groups by > 20% in 2022. Given the downward financial impacts of recent years these changes would result in some practices and OBLs closing and others moving care back to more expensive hospital-based facilities. While there is no pending legislative fix for this issue, there are several legislative options which could address this issue. We will continue to work with relevant agencies and congress to address this Urgent issue.
4. Support/Co-Sponsor H.R. 1667/S. 610, the “Dr. Lorna Breen Health Care Provider Protection Act”
   • Dr Lorna Breen was a NY Emergency Physician who after experiencing the strain of caring for COVID patients and becoming a COVID patient herself committed suicide. Her failure to obtain the necessary mental health support reveals a tremendous, short fall in our provider’s self-care system. Prevalence of physician burnout in the United States was 43.9% in 2017, which was higher than among other working adults. Physician burnout is recognized as a significant problem that has severe personal and professional consequences, including substance abuse, depression, suicide, poor clinical judgement and increased medical errors, decreased productivity, decreased patient satisfaction, and physician turnover. One of the major sources of physician burnout is compliance with time-consuming administrative burdens and red tape that do not add value to patient care or improve patient outcomes. The pandemic has only compounded these issues and added additional stress given the unprecedented challenges resulting from COVID-19.
   • HR1667 funds programs and studies aimed to prevent suicide, burnout, substance use disorders, and other mental health conditions and identifying and disseminating best practices for reducing and preventing suicide and burnout among health care professionals, among other things.

The post You Care About Patients. AVF Cares About Patients. Who Cares About You? AVF and SVS Lobby Congress For You and Patients appeared first on American Venous Forum.

Please know that while the AMA is a voice for all of our country’s physicians, the AVF leadership reads these documents with a more focused view of its impact on venous practitioners. An initial review of this Proposed Rule shows a potential decrease in vascular surgery payments of approximately 6% in 2022. This pay cut is among the most severe of any specialty. The underlying cause of this inequitable pay cut relates primarily to arcane rules governing the “practice expense” calculations.

The text of the proposed rule can be accessed here, and links to the press release and fact sheet are below:

CMS Press Release
Physician Fee Schedule Fact Sheet

Rest assured that your AVF leadership in collaboration with our likeminded surgical/venous societies will fully review these proposals and advocate on your behalf for a fair payment plan which more appropriately values the care you provide, and the high level of practice expenses required to run your offices.

Sincerely,

Mark Iafrati, MD
Chair, Health Policy Committee
healthpolicy@veinforum.org

The post 2022 Medicare Physician Fee Schedule Proposed Rule appeared first on American Venous Forum.

The post AMA COVID-19 Vaccine Messaging Guide appeared first on American Venous Forum.

The post Advocacy to Extend Current Moratorium on Medicare Sequester appeared first on American Venous Forum.

In December of 2020, their report (first link below) as well as the SVS Executive Board’s response and action plan to implement change (second link below) were published in the Journal of Vascular Surgery.

We applaud their efforts and encourage you to read and reflect on these two articles.

Ensuring Equity, Diversity and Inclusion in the Society for Vascular Surgery A Report of the Society for Vascular Surgery Task Force on Equity, Diversity and Inclusion
https://www.jvascsurg.org/article/S0741-5214(20)32602-1/fulltext?dgcid=raven_jbs_aip_email

The Society for Vascular Surgery Executive Board response to the Diversity, Equity and Inclusion Taskforce Report
https://www.jvascsurg.org/article/S0741-5214(20)32601-X/fulltext?dgcid=raven_jbs_aip_email

The post SVS Diversity, Equity and Inclusion Taskforce Shares Report and SVS Executive Board Responds appeared first on American Venous Forum.

Interim data from NHLBI examining 3 international trials suggesting decreased morbidity and  mortality for COVID-19 patients with therapeutic anticoagulation for patients not in the ICU.  Please share this important summary. IT CAN SAVE LIVES.
VIEW ARTICLE

The post NEW EXCITING RCT Data for Decreasing Morbidity and Mortality for COVID-19 with Therapeutic Anticoagulation appeared first on American Venous Forum.

Dear AVF Members,We are delighted to share with you updated LCDs for the Medicare Administrative Contractors (MACs) First Coast and Novitas. These LCDs which are scheduled to take effect on 12/27/20, are felt to be very reasonable and appropriate concerning the care of our patients with venous disease. Through the prolonged efforts of the AVF Health Policy Committee, in conjunction with the SVS and the AVLS Health Policy Committee, we have LCDs that finally are appropriate for patients, providers, and payers. In the future, hopefully these will either translate to a National Coverage Determination (NCD), or similar LCDs with the other MACs. Thanks to all the current and past members of the AVF HPC, and our friends at SVS and AVLS for this achievement.

Harold J. Welch, MD – President, AVF
Mark D. Iafrati, MD – Chair, AVF Health Policy Committee

First Coast Varicose Veins Future Effective policy: 12/27/20

First Coast Endovenous Stenting Future Effective Policy: 12/27/20

Novitas Solutions Varicose Veins Effective Policy: 12/27/20

Novitas Solutions Endovenous Stenting Future Effective Policy: 12/27/20

The post Updated LCDs from First Coast and Novitas appeared first on American Venous Forum.

The AVF Health Policy Committee, in collaboration with the SVS and AVLS have been busy advocating for our patients and our members.  This week, we submitted comment letters to CMS (Centers for Medicare and Medicaid Services) to address several significant regulatory issues.  The first addresses a long-standing non-coverage decision regarding catheter based mechanical embolectomy for Pulmonary Embolism.  The second addresses a proposed severe further reduction in the reimbursement for radiofrequency ablations over the next two years, based on an erroneous assumption about the prices we pay for RFA catheters.  By raising our collective voices on these important issues, we hope push our agenda of educating the regulators and ensuring access to these vital services for our Medicare and Medicaid patients.  Please take a moment to review these letters and feel free to add your voice with direct communication to your legislators in support of these important issues.

Comment Letter to Medicare and Medicaid Services

October 5th Proposed Rule Comments

The post AVF Advocacy in Action appeared first on American Venous Forum.